4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has announced the appointment of Katrin Rupalla, Ph.D, as an independent Non-Executive Director..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced an update on its lead Live Biotherapeutic candidate for..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced that David Norwood, Duncan Peyton and Alex Stevenson have..

4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, has today announced the final results for the Group for the..

4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of Live Biotherapeutics, has today announced that data from the completed Phase Ib clinical..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced an update on the clinical progress of its lead oncology..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces its participation in the inaugural Chardan Capital Markets LLC Microbiome..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced the publication of a paper outlining the mechanism and strong..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced the appointment of Ed Baracchini, PhD, and Professor Axel Glasmacher,..

4D pharma plc (LON: DDDD) and The University of Texas MD Anderson Cancer Center have today announced a strategic collaboration to evaluate 4D’s Live Biotherapeutic oncology..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced that David Norwood has purchased 10,000 ordinary shares in..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced that Duncan Peyton, David Norwood, Alex Stevenson and Thomas..

4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, noted today the recent fall in its share price, and confirms that..

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced the randomisation of the first patient in a Phase II..

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced the interim results for the Company and its subsidiaries for..

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced positive top-line results for its Phase Ib study of Thetanix in..

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announces the publication of data showing that specific single bacterial strains from..

4D Pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company’s Chief Scientific Officer, Dr. Alex Stevenson, has spoken..